SLC7A11 and neoplasm: Studies have revealed that the inhibition of SLC7A11 results in ferroptosis of tumor cells and may inhibit tumor progression (Han et al. 2022), indicating that SLC7A11 is a potential therapeutic target in ferroptosis-related diseases.